Results 21 to 30 of about 945,906 (220)

Transcatheter Aortic Valve Replacement in Aortic Stenosis: a Clinical Case

open access: yesКреативная хирургия и онкология, 2021
Background. Aortic valve stenosis is common with prevalence of about 0.5 %, peaking in people aged over 70 years mostly due to age-related valve calcification. The year 2002 was marked by the invention and use of the endovascular aortic replacement valve
V. V. Plechev   +8 more
doaj   +1 more source

Update on Transcatheter Aortic Valve Replacement [PDF]

open access: yesCardiology and Therapy, 2020
Transcatheter aortic valve replacement (TAVR) is a minimally invasive approach to treat symptomatic severe aortic stenosis. The patient populations that have been shown to benefit from this procedure continue to grow with time. Techniques and technology in TAVR persistently advance with a continued trend toward improved outcomes for patients.
Morgan H. Randall, Anthony A. Bavry
openaire   +3 more sources

Transcatheter aortic valve replacement valve in transcatheter aortic valve replacement valve for severe periprosthetic regurgitation

open access: yesHeart Views, 2020
The management of postprocedure severe aortic periprosthetic regurgitation after transcatheter aortic valve replacement (TAVR) is unknown. While valve-in-valve TAVR has been associated with favorable outcomes for degenerative surgically implanted bioprosthetic valves, there are no evidence-based guidelines for immediate TAVR valve in TAVR valve for ...
Sneha Nandy, Siu-Hin Wan, Kyle Klarich
openaire   +3 more sources

Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]

open access: yes, 2012
Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Wessely, Matthias   +6 more
core   +1 more source

Local versus general anesthesia for transcatheter aortic valve implantation (TAVR)- systematic review and meta-analysis [PDF]

open access: yes, 2014
The hypothesis of this study was that local anesthesia with monitored anesthesia care (MAC) is not harmful in comparison to general anesthesia (GA) for patients undergoing Transcatheter Aortic Valve Implantation (TAVR).TAVR is a rapidly spreading ...
Webb, J   +32 more
core   +2 more sources

Transcatheter Aortic Valve Replacement Programs: Clinical Outcomes and Developments

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
: Transcatheter aortic valve replacement is a relatively recent revolutionary treatment that has now become a standard procedure for treating severe aortic stenosis.
Vinayak Kumar   +4 more
doaj   +1 more source

Treatment of Early Trilogy Valve Aortic Insufficiency With Valve-in-Valve Transcatheter Aortic Valve Replacement. [PDF]

open access: yesCase Rep Cardiol
Aortic insufficiency (AI) is the third most common left valvular heart disease. Transcatheter aortic valve replacement (TAVR) is becoming popular in the treatment of AI.
van Nispen J, Massoomi M, Jeng E.
europepmc   +2 more sources

Advances in Transcatheter Aortic Valve Replacement [PDF]

open access: yesMethodist DeBakey Cardiovascular Journal, 2016
Transcatheter aortic valve replacement (TAVR) is becoming widely used for the treatment of symptomatic severe aortic stenosis in patients with high surgical risk. Data from The PARTNER Trial (Placement of AoRtic TraNscathetER Valves) and the Medtronic CoreValve® U.S. Pivotal Investigational Device Exemption trial indicate that survival for extreme-risk
Neal S, Kleiman, Michael J, Reardon
openaire   +2 more sources

Transcatheter Aortic Valve Replacement for Degenerated Transcatheter Aortic Valves: The TRANSIT International Project

open access: yesCirculation: Cardiovascular Interventions, 2021
Background: Transcatheter aortic valve replacement (TAVR) has determined a paradigm shift in the treatment of patients with severe aortic stenosis. However, the durability of bioprostheses is still a matter of concern, and little is known about the management of degenerated TAV.
Luca Testa   +38 more
openaire   +6 more sources

Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. [PDF]

open access: yes, 2014
OBJECTIVE: To use patient-level data from the ADVANCE study to evaluate the cost-effectiveness of transcatheter aortic valve implantation (TAVI) compared to medical management (MM) in patients with severe aortic stenosis from the perspective of the UK ...
Busca, R   +48 more
core   +1 more source

Home - About - Disclaimer - Privacy